Operating Expenses Changement Date
Acadia Pharmaceuticals USD 196.1M 73.38M 2023-12
Alnylam Pharmaceuticals USD 556.12M 19.46M 2023-12
Amarin USD 87.51M 16.62M 2023-09
BioCryst Pharmaceuticals USD 98.66M 33.55M 2023-09
BioMarin Pharmaceutical USD 631.99M 76.32M 2023-12
Esperion Therapeutics USD 61.5M 1.34M 2023-09
Galectin Therapeutics USD 9.17M 163K 2023-09
Halozyme Therapeutics USD 129M 1.25M 2023-12
Incyte USD 826.07M 121.75M 2023-12
Insmed USD 261.96M 35.22M 2023-12
Ionis Pharmaceuticals USD 303.83M 14.26M 2023-12
Neurocrine Biosciences USD 357.6M 21.5M 2023-09
PTC Therapeutics USD 438.79M 124.05M 2023-12
Sarepta Therapeutics USD 380.16M 87.4M 2023-09
Ultragenyx Pharmaceutical USD 249.44M 6.29M 2023-12
United Therapeutics USD 354.6M 72.2M 2023-12



DBV Technologies Les Charges D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2024.